Skip to Content

Welcome to Revance

Revance is a biotechnology company focused on innovative aesthetic and therapeutic offerings, including our next-generation investigational neuromodulator product, DaxibotulinumtoxinA for Injection.

We believe in leaving bureaucracy behind. We value speed, audacity, grit and empathy, and empower our teams to reimagine the status quo.

Aesthetics

Our premium category in facial aesthetics is focused on differentiated and improved outcomes, value-based pricing and an elevated experience for HCPs and patients.

Learn More

Therapeutics

We are innovating new therapeutic treatments that meaningfully transform patient experiences in muscle movement and pain disorders

Learn More

Meet the Board of Directors

Our board brings together exceptional executives in science, healthcare, and business who dare to make a difference.

Mark Foley

President and CEO of Revance Therapeutics, Inc.

Our Leadership

Daring to Make a Difference.

Revance’s leadership is committed to disrupting the status quo and has deep experience commercializing products in highly competitive markets. As a group, we represent more than a century of experience launching innovative products that change people’s lives.

We believe in leaving bureaucracy behind. We value speed, audacity, grit and empathy, and empower our teams to reimagine the status quo.

Mark Foley

President and CEO of Revance Therapeutics, Inc.

Dwight Moxie

Senior Vice President, General Counsel & Corporate Secretary

Back to top